# Abacus Global Management, Inc.: overview ABX · NYSE · CIK 1814287 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/abx.md) · [Financials](/companies/abx/financials.md) · [Filings](/companies/abx/filings.md) · [Insiders](/companies/abx/insiders.md) Latest reported revenue: [$73.0m](/filings/0001628280-26-055287.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-055287). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [28.1](/filings/0001628280-25-050614.md) | [33.2 d](/filings/0001628280-26-017775.md) | [44.1](/filings/0001628280-26-033136.md) | [56.2](/filings/0001628280-26-055287.md) | [63.0](/filings/0001628280-25-050614.md) | [71.9 d](/filings/0001628280-26-017775.md) | [59.4](/filings/0001628280-26-033136.md) | [73.0](/filings/0001628280-26-055287.md) | | Gross margin | % | [92.2%](/filings/0001628280-25-050614.md) | [88.8% d](/filings/0001628280-26-017775.md) | [83.9%](/filings/0001628280-26-033136.md) | [89.2%](/filings/0001628280-26-055287.md) | [87.8%](/filings/0001628280-25-050614.md) | [88.8% d](/filings/0001628280-26-017775.md) | [89.4%](/filings/0001628280-26-033136.md) | [87.6%](/filings/0001628280-26-055287.md) | | Operating margin | % | [24.3%](/filings/0001628280-25-050614.md) | [(50.5%) d](/filings/0001628280-26-017775.md) | [47.6%](/filings/0001628280-26-033136.md) | [40.1%](/filings/0001628280-26-055287.md) | [35.6%](/filings/0001628280-25-050614.md) | [31.7% d](/filings/0001628280-26-017775.md) | [30.9%](/filings/0001628280-26-033136.md) | [29.4%](/filings/0001628280-26-055287.md) | | Net margin | % | [(18.2%)](/filings/0001628280-25-050614.md) | [(55.0%) d](/filings/0001628280-26-017775.md) | [10.5%](/filings/0001628280-26-033136.md) | [31.3%](/filings/0001628280-26-055287.md) | [11.2%](/filings/0001628280-25-050614.md) | [10.1% d](/filings/0001628280-26-017775.md) | [12.2%](/filings/0001628280-26-033136.md) | [9.1%](/filings/0001628280-26-055287.md) | | Diluted EPS | $ per share | [(0.07)](/filings/0001628280-25-050614.md) | not reported | [0.05](/filings/0001628280-26-033136.md) | [0.18](/filings/0001628280-26-055287.md) | [0.07](/filings/0001628280-25-050614.md) | not reported | [0.07](/filings/0001628280-26-033136.md) | [0.07](/filings/0001628280-26-055287.md) | | Free cash flow | $m | [(52.5) d](/filings/0001628280-25-050614.md) | [(92.2) d](/filings/0001628280-26-017775.md) | [(61.8)](/filings/0001628280-26-033136.md) | [75.7 d](/filings/0001628280-26-055287.md) | [(32.9) d](/filings/0001628280-25-050614.md) | [(7.6) d](/filings/0001628280-26-017775.md) | [91.6](/filings/0001628280-26-033136.md) | [38.4 d](/filings/0001628280-26-055287.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | [44.7](/filings/0001814287-24-000035.md) | [66.4](/filings/0001814287-25-000006.md) | [112](/filings/0001628280-26-017775.md) | [235](/filings/0001628280-26-017775.md) | | Gross margin | % | not reported | [86.8%](/filings/0001814287-24-000035.md) | [90.2%](/filings/0001814287-25-000006.md) | [89.8%](/filings/0001628280-26-017775.md) | [87.7%](/filings/0001628280-26-017775.md) | | Operating margin | % | not reported | [75.3%](/filings/0001814287-24-000035.md) | [36.3%](/filings/0001814287-25-000006.md) | [(0.8%)](/filings/0001628280-26-017775.md) | [37.7%](/filings/0001628280-26-017775.md) | | Net margin | % | not reported | [70.9%](/filings/0001814287-24-000035.md) | [14.3%](/filings/0001814287-25-000006.md) | [(21.4%)](/filings/0001628280-26-017775.md) | [15.5%](/filings/0001628280-26-017775.md) | | Diluted EPS | $ per share | not reported | [0.63](/filings/0001814287-24-000035.md) | [0.16](/filings/0001814287-25-000006.md) | [(0.34)](/filings/0001628280-26-017775.md) | [0.36](/filings/0001628280-26-017775.md) | | Free cash flow | $m | not reported | [10.7](/filings/0001814287-24-000035.md) | [(64.2)](/filings/0001814287-25-000006.md) | [(210)](/filings/0001628280-26-017775.md) | [(26.6)](/filings/0001628280-26-017775.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/abx/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $24.9m | 2,323,337 | | Added +206,470 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $24.5m | 2,283,996 | | Reduced −445,082 | | [MENDON CAPITAL ADVISORS CORP](/funds/1177043.md) | 2026-06-30 | $19.3m | 1,800,000 | | Reduced −149,321 | | [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $18.2m | 1,700,000 | | Reduced −100,000 | | [ASHFORD CAPITAL MANAGEMENT INC](/funds/897070.md) | 2026-06-30 | $17.9m | 1,670,673 | | Added +805,773 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.1m | 1,597,471 | | Reduced −234,139 | | [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $12.9m | 1,106,706 | | Reduced −223,432 | | [Alta Fundamental Advisers LLC](/funds/1641604.md) | 2026-06-30 | $11.8m | 1,097,639 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $10.7m | 999,868 | | Reduced −54,780 | | [STATE OF WISCONSIN INVESTMENT BOARD](/funds/854157.md) | 2026-06-30 | $9.3m | 872,323 | | Reduced −93,719 | ## Recent filings [All 442 filings](/companies/abx/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-24 | 16:57 ET | [8-K](/filings/0001628280-26-058671.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-058671 | | 2026-08-13 | 16:39 ET | [8-K](/filings/0001628280-26-056792.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-056792 | | 2026-08-10 | 16:38 ET | [10-Q](/filings/0001628280-26-055287.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055287 | | 2026-08-06 | 16:30 ET | [8-K](/filings/0001628280-26-054378.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-054378 | | 2026-07-02 | 16:05 ET | [8-K](/filings/0001628280-26-046875.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-046875 | | 2026-06-10 | 08:59 ET | [8-K](/filings/0001628280-26-042072.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-042072 | | 2026-06-04 | 16:40 ET | [8-K](/filings/0001628280-26-040854.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-040854 | | 2026-05-27 | 11:07 ET | [8-K](/filings/0001628280-26-038331.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-038331 | | 2026-05-11 | 07:37 ET | [10-Q](/filings/0001628280-26-033136.md) | Quarterly report, period 2026-03-31 | 0001628280-26-033136 | | 2026-05-07 | 16:27 ET | [8-K](/filings/0001628280-26-032209.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-032209 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-017775.md), filed Mar 13, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3504a03a-079a-4f0e-b888-bf4fc50f4dc4) ## About the filer - CIK: 1814287 - Tickers: ABX, ABXL - Exchange: NYSE - SIC code: 6282 Investment Advice - State of incorporation: DE - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 17:21 ET. No prices; not investment advice.